Reduction of invasive biopsies by proteome analysis!

Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection

Patients developing AKI can now be identified early, enabling timely initiation of treatment!

Multicentric validation of diagnostic tests for bladder cancer

DisCo-I project

Urinary peptidomic profile predicts age-related chronic diseases, excessive fibrosis

Cover of the October issue 2021 of the Proteomics journal was designed by Mosaiques

CoV-50 test to determine complications after Covid-19 disease is ready to use!

COVID-19 pandemic

Early detection of significant prostate cancer

Pages